Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barton

Showing results (31-40 of 296) with videos related to

Pageof 30
Sort By:
Rheumatology Advances in Practice|April 8, 2024
Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysisSean P Gavan, Katherine Payne, Anne Barton
Annals of the Rheumatic Diseases|January 4, 2023
Genetically proxied TYK2 inhibition is associated with reduced sarcoidosis susceptibilitySizheng Steven Zhao, Anne Barton, John Bowes
The Patient|June 18, 2021
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice ExperimentCaroline M Vass, Anne Barton, Katherine Payne
Expert Review of Clinical Immunology|September 21, 2012
Genetics and the impact on treatment protocols in patients with rheumatoid arthritisIbrahim Ibrahim, Sally-Anne Owen, Anne Barton
Clinical Therapeutics|July 29, 2023
Genetic Studies Investigating Susceptibility to Psoriatic Arthritis: A Narrative ReviewMehreen Soomro, Ryan Hum, Anne Barton, et al.
The Journal of Rheumatology|July 4, 2012
Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritisIbrahim Ibrahim, Anne Barton, Abdulla Ibrahim, et al.
Arthritis and Rheumatism|August 2, 2005
TNFR2 is not associated with rheumatoid arthritis susceptibility in a Caucasian populationCatherine Potter, Jane Worthington, Alan Silman, et al.
Arthritis Care & Research|October 11, 2014
Reply: To PMID 24339425Lis Cordingley, Rita Prajapati, Catharine Morgan, et al.
Biomarkers in Medicine|June 17, 2015
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritisJames Oliver, Darren Plant, Amy P Webster, et al.
Annals of the Rheumatic Diseases|March 15, 2013
The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritisSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Pageof 30

Showing results (31-40 of 296) with videos related to

Sort By:
Pageof 30
Rheumatology Advances in Practice|April 8, 2024
Overcoming provider barriers to therapeutic drug monitoring of tumour necrosis factor inhibitors for rheumatoid arthritis: a qualitative analysisSean P Gavan, Katherine Payne, Anne Barton
Annals of the Rheumatic Diseases|January 4, 2023
Genetically proxied TYK2 inhibition is associated with reduced sarcoidosis susceptibilitySizheng Steven Zhao, Anne Barton, John Bowes
The Patient|June 18, 2021
Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice ExperimentCaroline M Vass, Anne Barton, Katherine Payne
Expert Review of Clinical Immunology|September 21, 2012
Genetics and the impact on treatment protocols in patients with rheumatoid arthritisIbrahim Ibrahim, Sally-Anne Owen, Anne Barton
Clinical Therapeutics|July 29, 2023
Genetic Studies Investigating Susceptibility to Psoriatic Arthritis: A Narrative ReviewMehreen Soomro, Ryan Hum, Anne Barton, et al.
The Journal of Rheumatology|July 4, 2012
Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritisIbrahim Ibrahim, Anne Barton, Abdulla Ibrahim, et al.
Arthritis and Rheumatism|August 2, 2005
TNFR2 is not associated with rheumatoid arthritis susceptibility in a Caucasian populationCatherine Potter, Jane Worthington, Alan Silman, et al.
Arthritis Care & Research|October 11, 2014
Reply: To PMID 24339425Lis Cordingley, Rita Prajapati, Catharine Morgan, et al.
Biomarkers in Medicine|June 17, 2015
Genetic and genomic markers of anti-TNF treatment response in rheumatoid arthritisJames Oliver, Darren Plant, Amy P Webster, et al.
Annals of the Rheumatic Diseases|March 15, 2013
The potential use of expression profiling: implications for predicting treatment response in rheumatoid arthritisSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Pageof 30